TRUST CO OF VERMONT - OCULAR THERAPEUTIX INC ownership

OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 114 filers reported holding OCULAR THERAPEUTIX INC in Q3 2023. The put-call ratio across all filers is 0.46 and the average weighting 0.9%.

Quarter-by-quarter ownership
TRUST CO OF VERMONT ownership history of OCULAR THERAPEUTIX INC
ValueSharesWeighting
Q3 2023$15,700
-23.9%
5,000
+25.0%
0.00%0.0%
Q2 2023$20,640
-2.1%
4,0000.0%0.00%0.0%
Q1 2023$21,080
+87.5%
4,0000.0%0.00%0.0%
Q4 2022$11,2404,0000.00%
Other shareholders
OCULAR THERAPEUTIX INC shareholders Q3 2023
NameSharesValueWeighting ↓
SUMMER ROAD LLC 3,804,788$15,105,00043.34%
Versant Venture Management, LLC 2,215,384$8,795,074,0002.90%
Opaleye Management Inc. 1,900,000$7,543,0002.09%
SV Health Investors, LLC 628,236$2,494,0001.46%
Endurant Capital Management LP 716,124$2,843,0001.12%
DELTEC ASSET MANAGEMENT LLC 824,747$3,274,0000.72%
NOTTINGHAM ADVISORS, INC. 146,946$583,0000.08%
Jump Trading, LLC 39,255$156,0000.05%
Man Group plc 1,723,456$6,842,0000.03%
JGP Global Gestao de Recursos Ltda. 13,880$55,0000.02%
View complete list of OCULAR THERAPEUTIX INC shareholders